The impact of COVID-19 on lung cancer diagnostics – a multicentre comparison of 2019/2020 data
Neal Navani(University College London Hospitals NHS Foundation Trust), David Baldwin(University of Nottingham), Laura Succony, Berkay Karahacioglu, Emma O’Dowd, Elizabeth Fuller, Sam M. Janes(University College London), Robert C. Rintoul(University of Edinburgh), Matthew Evison, Ian Woolhouse(University Hospitals Birmingham NHS Foundation Trust), Sinan Eccles, Amyn Bhamani(University College London)
Cited by 3
Related Papers
Single-cell multi-omics analysis of the immune response in COVID-19
|Nature Medicine|2021|826
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
|Nature Medicine|1999|740
Infectious diseases in the aftermath of monsoon flooding in Pakistan
|Asian Pacific Journal of Tropical Biomedicine|2011|103
Early human lung immune cell development and its role in epithelial cell fate
|Science Immunology|2023|91